CONTENTS
Terms of Reference
Summary
Chapter 1: Introduction
Chapter 2: Key Issues
Scientific Infrastructure: Planning and
Governance
Availability of scientific infrastructure
Box 1: The Diamond Light Source
Box 2: Understanding the Natural Environment
Box 3: Understanding the Genome
Investment following the 2010 Comprehensive
Spending Review
Table 1: Science capital announcements at
and following the 2010 CSR
Table 2: Innovation Capital Expenditure announced
at the 2010 Comprehensive Spending Review and in the subsequent
announcements (2011-2015)
Long term planning and governance arrangements
Box 4: Current planning and governance mechanisms
Table 3: Allocation of £600 million
of science and innovation capital funding
Not just machines
Operational costs
People and skills
Shared benefits
Public Sector Research Establishments
Mid-range scientific infrastructure
National scientific infrastructure
European and International
Box 5: CERN
Box 6: Examples of international infrastructure
projects hosted in the UK
Industry
Box 7: Heptares Therapeutics
Monitoring and evaluation
Chapter 3: Conclusions and Recommendations
Scientific Infrastructure: Planning and
Governance
Not just machines
Shared benefits
Monitoring and evaluation
Appendix 1: List of Members and Declarations
of Interest
Appendix 2: List of Witnesses
Appendix 3: Call for Evidence
Appendix 4: Supplementary Data
Appendix 5: Seminar held at the House of
Lords
Appendix6: Abbreviations and Acronyms
Appendix 7: Recent reports from the House
of Lords Science and Technology Committee
NOTE: Evidence is published online at www.parliament.uk/hlscience
and available for inspection at the Parliamentary
Archives (020 7219 5314)
References in footnotes to the Report are as follows:
Q refers to a question in oral evidence;
Witness names without a question reference refer
to written evidence
| 
